Community
There are places in your physical and virtual neighbourhood designed to bring people together in good faith and spirit – to share resources, good times and kindness. There are wonderful initiatives out there that are
There are places in your physical and virtual neighbourhood designed to bring people together in good faith and spirit – to share resources, good times and kindness. There are wonderful initiatives out there that are
Since this is more of a personal endeavour and constantly evolving piece rather than a final, done and dusted publication, you might notice unfinished thoughts and lazy plagiarism here and there. It was important to
Daclizumab, marketed as Zinbryta, was approved for the treatment of relapsing-remitting multiple sclerosis (MS) in the USA and Europe in summer 2016. Daclizumab has shown superior efficacy when compared to placebo and a standard treatment (AVONEX®, interferon beta-1a) and is
Continue …Daclizumab – Manipulating the immune system in unexpected ways
Elahe is originally from Iran, and I always find it fascinating to talk to her. Why? Because I can learn about an unfamiliar world. I don’t know an awful lot about Iran; just bits I
Continue …Dr Elahe Radmaneshfar – What comes after two dream jobs and a PhD?
It is a specialist skill to write in a manner that is accepted and credible in the academic realm. To complicate matters, different scientific journals have varying styles and expectations. The acceptance of a paper
Continue …Dr Joanna Mackie – Helping Researchers Get Published
After I tweeted about my recent post about Immunium, another Twitter user made me aware of iCancer. Why? – Because the clinical trial financed through the iCancer fundraising campaign used the Ad5PTDf35-adenovirus vector which Immunicum
Continue …iCancer – The first step into the future of funding clinical trials?
I thought I kick off the year with an article about Immunicum, a Swedish company I stumbled across a week or so ago. As an immunologist by training I have a soft spot for companies
Continue …Immunicum – Scalable Personalised Cancer Immunotherapy
Exsel Group are certainly doing something right if the company’s recent accolades are anything to go by. Having started in 2014 with just three members of staff; today the IT and communications company can boast a
Continue …Tom McDonald – Getting Deloitte Excited About Exsel Group
The first time I met Beverley was when we were both helping at a conference that was organised by postgraduates for prospective research students at the University of Aberdeen in 2012 – the PhD Journey Conference,
Continue …Dr Beverley Minter – The scientist who helped shape Blue Steens’ purpose